| Phosphodiesterase-4 inhibition in Parkinson’s disease: molecular insights and therapeutic potential D Roy, S Balasubramanian, PT Krishnamurthy, P Sola, E Rymbai Cellular and Molecular Neurobiology 43 (6), 2713-2741, 2023 | 4 | 2023 |
| The identification of c-Abl inhibitors as potential agents for Parkinson’s disease: a preliminary in silico approach E Rymbai, D Roy, S Jupudi, V Srinivasadesikan Molecular Diversity, 1-15, 2024 | 1 | 2024 |
| Advances of cassava starch-based composites in novel and conventional drug delivery systems: a state-of-the-art review S Das, MK Das, T Jamatia, B Bhattacharya, R Mazumder, PK Yadav, ... RSC Pharmaceutics, 2024 | 1 | 2024 |
| The Biochemical Basis of Neurological Disorders N Sailo, D Roy, R Bezbaruah, BB Kakoti Current Trends in the Diagnosis and Management of Metabolic Disorders, 279-291, 2023 | | 2023 |
| In-silico screening of Acacia pennata and Bridelia retusa reveals pinocembrin-7-O-β-D-glucopyranoside as a promising β-lactamase inhibitor to combat antibiotic … AK Umar, D Roy, M Abdalla, Y Modafer, N Al-Hoshani, H Yu, ... Journal of Biomolecular Structure and Dynamics, 1-13, 2023 | | 2023 |
| Tangeretin-a special polymethoxyflavones: An insight into its pharmacological and therapeutic effects on diabetes FP Nonglang, D Roy, D Newar, S Bhan GSC Biological and Pharmaceutical Sciences 23 (1), 127-136, 2023 | | 2023 |
| Role of estrogen receptors in cancer: a special emphasis on the therapeutic potential of estrogen receptor ß. E Rymbai, D Sugumar, D Roy, D Selvaraj Pharmaceutical Sciences Asia 49 (5), 2022 | | 2022 |
Emdormi RymbaiJSS College of Pharmacy, OotyVerified email at jssuni.edu.in
